Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Kiromic BioPharma Inc logo

Kiromic BioPharma Inc

Sector: Professional, Scientific, and Technical Services   

Industry: Research and Development in Biotechnology

2.64
 
USD
  
0.33
  
(14.07%)
Optionable: Yes  Market Cap: 3 M  90-day average vol: 4,743

Previous close: 2.31  Open: 2.31  Bid:   Ask:
52 week range    
0.16   
   8.97
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Wednesday 1st May 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

KRBP Cash Flow

Annual
Invalid dateDec-20Dec-21Dec-22
(Increase) Decrease in other working capital6700.0
(Increase) Decrease in payables-7700.01 M4 M
(Increase) Decrease in receivables9800.016200.0
AssetImpairmentCharge22200.0430000.0
CapitalExpenditureReported1 M2 M5 M
Cash at beginning of period2 M10 M25 M
Cash at end of period10 M25 M645200.0
Cash flow-6 M-20 M-24 M
CashFlowFromContinuingInvestingActivities-1 M-2 M-5 M
ChangeInAccountPayable-7700.01 M4 M
ChangeInAccruedExpense112900.0406800.0282700.0
ChangeInInterestPayable142100.0
ChangeInPayablesAndAccruedExpense105200.02 M4 M
ChangeInPrepaidAssets-499700.0-1 M655700.0
ChangeInWorkingCapital-394500.0710300.05 M
ChangesInAccountReceivables9800.016200.0
CommonStockPayments-3 M-3 M
Depreciation200000.0469800.02 M
Depreciation unreconciled200000.0469800.02 M
DepreciationAndAmortization200000.0469800.02 M
FinancingCashFlow16 M37 M4 M
Free cash flow-8 M-22 M-29 M
GainLossOnSaleOfPPE-12800.0
InterestPaidSupplementalData3100.012200.012200.0
Issuance of capital stock15 M40 M
Issuance of debt352400.092200.0102700.0
IssuanceOfCapitalStock15 M40 M
IssuanceOfDebt352400.092200.04 M
Net cash from financing activities16 M37 M4 M
Net cash from investing activities-1 M-2 M-5 M
Net cash from operating activities-6 M-20 M-24 M
Net change in cash & cash equivalents8 M15 M-25 M
Net income from continuing operations-19 M-26 M-35 M
NetBusinessPurchaseAndSale84000.0
NetCommonStockIssuance12 M37 M
NetIssuancePaymentsOfDebt352400.092200.04 M
NetLongTermDebtIssuance4 M
NetPPEPurchaseAndSale-1 M-2 M-5 M
NetPreferredStockIssuance3 M
Operating (gains) losses-105800.0381400.0
Other financing charges net115600.0
Other non-cash items13 M4 M4 M
PreferredStockIssuance3 M
ProceedsFromIssuanceOfWarrants4900.0
ProceedsFromStockOptionExercised125400.0
Purchase of property plant & equipment-1 M-2 M-5 M
Purchase of short term investments4 M
PurchaseOfPPE-1 M-2 M-5 M
Repayment of debt-200000.0
RepaymentOfDebt-188100.0-573700.0-708000.0
Repurchase of capital stock-3 M-3 M
Revenue per share9900.0
SaleOfBusiness84000.0
SaleOfPPE15000.0
ShortTermDebtIssuance540500.0665900.0610700.0
ShortTermDebtPayments-188100.0-573700.0-508000.0
StockBasedCompensation13 M4 M1 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University